N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine

C20H20N6O3 — CID 127244194

IUPACN-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine
SMILESCOc1cc(/C=N/Nc2nc3ccccc3n2C)ccc1OCc1nonc1C
InChIInChI=1S/C20H20N6O3/c1-13-16(25-29-24-13)12-28-18-9-8-14(10-19(18)27-3)11-21-23-20-22-15-6-4-5-7-17(15)26(20)2/h4-11H,12H2,1-3H3,(H,22,23)/b21-11+
InChIKeyHUEDCXAZHHKRAP-SRZZPIQSSA-N
MW392.42 g/mol
LogP3.30
Rot. Bonds7

About N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine

N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine (PubChem CID 127244194) has the molecular formula C20H20N6O3 and a molecular weight of 392.42 g/mol. Its IUPAC name is N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine.

Molecular Properties

Compound NameN-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine
PubChem CID127244194
Molecular FormulaC20H20N6O3
Molecular Weight392.42 g/mol
Exact Mass392.16
IUPAC NameN-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine
SMILESCOc1cc(/C=N/Nc2nc3ccccc3n2C)ccc1OCc1nonc1C
InChIInChI=1S/C20H20N6O3/c1-13-16(25-29-24-13)12-28-18-9-8-14(10-19(18)27-3)11-21-23-20-22-15-6-4-5-7-17(15)26(20)2/h4-11H,12H2,1-3H3,(H,22,23)/b21-11+
InChIKeyHUEDCXAZHHKRAP-SRZZPIQSSA-N
XLogP3.30
TPSA99.59 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500392.42
LogP ≤ 53.30
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine?
The IUPAC name of N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine (CID 127244194) is N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine.
What is the SMILES notation for N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine?
The canonical SMILES for N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine is COc1cc(/C=N/Nc2nc3ccccc3n2C)ccc1OCc1nonc1C.
What is the InChIKey of N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine?
The InChIKey is HUEDCXAZHHKRAP-SRZZPIQSSA-N. The full InChI is InChI=1S/C20H20N6O3/c1-13-16(25-29-24-13)12-28-18-9-8-14(10-19(18)27-3)11-21-23-20-22-15-6-4-5-7-17(15)26(20)2/h4-11H,12H2,1-3H3,(H,22,23)/b21-11+.
What are the key properties of N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine?
N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine has a molecular weight of 392.42 g/mol, XLogP of 3.30, 7 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(E)-[3-methoxy-4-[(4-methyl-1,2,5-oxadiazol-3-yl)methoxy]phenyl]methylideneamino]-1-methylbenzimidazol-2-amine is sourced from PubChem (CID 127244194), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).